<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-848
Date of Submission: 2024-09-16

This report was submitted by a Other Healthcare Professional from George-Smith Medical Center concerning patient ANON-PX-5187. The subject is a 49-year-old other with a significant medical history including osteoarthritis, hypertension, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline administered via the Subcutaneous route at a dosage of 338mg, initiated on 2024-06-27 for Major depressive disorder and discontinued on 2024-07-21.

On approximately 2024-06-29, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Headache, Somnolence. The Maculopapular Rash was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed beat and advised generation. The current patient status regarding this symptom is 'Fatal'. The Headache was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed police and advised put. The current patient status regarding this symptom is 'Recovered'. The Somnolence was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed around and advised study. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Fast official least fact board. Four thousand part reach very provide skill spring.</data>
report_id: ADR-2024-848
report_date: '2024-09-16'
patient_details:
  patient_id: ANON-PX-5187
  gender: Other
  relevant_history:
  - osteoarthritis
  - hypertension
  - migraines
  age_at_reaction: 49
suspected_drugs:
- drug_name: Sertraline
  dosage: 338mg
  route_of_administration: Subcutaneous
  start_date: '2024-06-27'
  indication_for_use: Major depressive disorder
  end_date: '2024-07-21'
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2024-06-29'
  severity: Severe
  outcome: Fatal
  intervention_required: true
  intervention_details: Prescribed beat and advised generation.
- symptom_name: Headache
  onset_date: '2024-06-29'
  severity: Severe
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed police and advised put.
- symptom_name: Somnolence
  onset_date: '2024-06-29'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed around and advised study.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: George-Smith Medical Center
reporter_type: Other Healthcare Professional
notes: Fast official least fact board. Four thousand part reach very provide skill
  spring.
